Form 4 for ENTG ENTEGRIS INC
Accepted 2021-11-01 00:00:00 ET · period of report 2021-10-28 · accession 0001485429-21-000008 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-11-01 | 2021-10-28 | ENTG | Edlund Todd James | EVP, COO | S - Sale+OE | $137.79 | -20.2K | 174.1K | -10% | -$2.79M |
| D | 2021-11-01 | 2021-10-28 | ENTG | Edlund Todd James | EVP, COO | M - OptEx | $33.33 | +20.2K | 188.4K | +12% | +$674.8K |
| D | 2021-11-01 | 2021-10-28 | ENTG | Edlund Todd James | EVP, COO | M - OptEx | $0.00 | -20.2K | 20.2K | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-10-28 | S | D | 1,300 | $136.79 | 187,122 | D | — | — | (F1) These shares were sold pursuant to a Rule 10b-5 Trading Plan established by the Reporting Person on August 5, 2021. (F2) The price reported in column 4 is a weighted average price reported in reliance on a letter from the Office of Chief Counsel, Securities and Exchange Commission's Division of Corporate Finance to the Society of Corporate Governance Professionals dated June 25, 2008. These shares were sold in multiple transactions at prices ranging from $136.11 to $137.08, inclusive. The reporting person undertakes to provide Entegris, Inc., any shareholder of Entegris, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. |
| 2 | Common | Common Stock | 2021-10-28 | S | D | 5,959 | $138.33 | 168,176 | D | — | — | (F1) These shares were sold pursuant to a Rule 10b-5 Trading Plan established by the Reporting Person on August 5, 2021. (F4) The price reported in column 4 is a weighted average price reported in reliance on a letter from the Office of Chief Counsel, Securities and Exchange Commission's Division of Corporate Finance to the Society of Corporate Governance Professionals dated June 25, 2008. These shares were sold in multiple transactions at prices ranging from $138.11 to $138.71, inclusive. The reporting person undertakes to provide Entegris, Inc., any shareholder of Entegris, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. |
| 3 | Common | Common Stock | 2021-10-28 | S | D | 12,987 | $137.64 | 174,135 | D | — | — | (F1) These shares were sold pursuant to a Rule 10b-5 Trading Plan established by the Reporting Person on August 5, 2021. (F3) The price reported in column 4 is a weighted average price reported in reliance on a letter from the Office of Chief Counsel, Securities and Exchange Commission's Division of Corporate Finance to the Society of Corporate Governance Professionals dated June 25, 2008. These shares were sold in multiple transactions at prices ranging from $137.11 to $138.10, inclusive. The reporting person undertakes to provide Entegris, Inc., any shareholder of Entegris, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. |
| 4 | Common | Common Stock | 2021-10-28 | M | A | 20,246 | $33.33 | 188,422 | D | — | — | |
| 5 | Derivative | Employee Stock Option (Right to Buy) | 2021-10-28 | M | D | 20,246 | $0.00 | 20,246 | D | $33.33 · — to 2026-02-19 | 20,246 Common Stock | (F5) The option vests in four equal annual installments. The first two installments became exercisable on February 19, 2020 and February 19, 2021. The remaining installments will become exercisable on February 19, 2022 and February 19, 2023. |